Find uplifting stories about heroes, innovations, and solutions
10 results for "lung cancer treatment"
Multiple research teams discovered that aggressive lung cancer cells form actual connections with brain neurons, and drugs that block these connections slow tumor growth in mice. The breakthrough could lead to new treatment options for one of the deadliest cancers.
A groundbreaking $4 million clinical trial in Canada is pairing gut bacteria capsules with immunotherapy to help lung cancer patients who aren't responding to standard treatments. If successful, the LUNA-2 trial could extend lives and reduce side effects for thousands of Canadians.
Researchers analyzed real-world data from 940 patients to compare five lung cancer drugs, finding clearer answers about which treatments work best. The findings could help doctors and patients make smarter decisions about care.
A new targeted therapy for a rare form of lung cancer just earned priority review from the FDA, potentially offering hope to thousands of patients who currently have limited treatment options. The drug specifically targets HER2 mutations found in about 2-4% of lung cancer cases.
New targeted therapies and immunotherapies for lung cancer are now reaching over 60% of patients with advanced disease, a dramatic improvement in treatment access. Fifteen states have enacted laws requiring insurance coverage for biomarker testing that helps match patients to lifesaving treatments.
A powerful new combination therapy just gained approval to help patients fighting an aggressive form of lung cancer live longer. The treatment offers hope for thousands diagnosed with extensive-stage small cell lung cancer each year.
Two new therapies just won backing from European regulators to treat one of the deadliest forms of lung cancer. The treatments fill critical gaps that have frustrated doctors for decades.
A grandmother's lung cancer treatment once cost her family their life savings. Now, thanks to China's expanded medical insurance, over 230 cancer drugs are affordable for millions of aging families.
A groundbreaking study from China reveals that lung cancer patients who receive immunochemotherapy before 3pm survive nearly twice as long. The discovery could transform treatment timing at no extra cost.
Scientists at Duke discovered an antibody that naturally helps some immune systems beat cancer—and turned it into an experimental drug. Early trials show promise in stopping lung tumors from growing.